UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000048922 |
|---|---|
| Receipt number | R000055743 |
| Scientific Title | Autonomic responses of human organs induced by acupuncture and thermal stimulation: Randomized controlled trial evaluating electrocardiogram, finger plethysmogram, and local skin blood flow |
| Date of disclosure of the study information | 2022/09/15 |
| Last modified on | 2022/09/13 15:03:29 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Autonomic responses of human organs induced by acupuncture and thermal stimulation:
Randomized controlled trial evaluating electrocardiogram, finger plethysmogram, and local skin blood flow
Acronym
Autonomic responses of human organs induced by acupuncture and thermal stimulation
Scientific Title
Autonomic responses of human organs induced by acupuncture and thermal stimulation:
Randomized controlled trial evaluating electrocardiogram, finger plethysmogram, and local skin blood flow
Scientific Title:Acronym
Autonomic responses of human organs induced by acupuncture and thermal stimulation
Region
| Japan |
Condition
Condition
Healthy condition
Classification by specialty
| Not applicable | Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
This study will examine the effects of acupuncture and thermal stimulation on haemodynamics using electrocardiogram, finger plethysmogram, and local skin blood flow. The differences in response by acupuncture and thermal stimulation will also be examined.
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Measurement of the electrocardiogram (ECG): Electrodes are placed on the chest induction I and recordings are made. The instantaneous heart rate, QT interval, QTc interval are calculated from the recorded ECG. In addition, HRV analysis is performed as an indicator of cardiac autonomic function.
The ECG is measured for 10 minutes before stimulation, 2 minutes during stimulation, and 15 minutes after stimulation, for a total of 27 minutes.
Key secondary outcomes
Measurement of the finger plethysmogram: A pulse transducer (MP100, AD Instruments) is attached to the tip of the right index finger to record and calculate wave height values.
Measurement of the local skin blood flow: A laser Doppler skin blood flow meter (ALF-21, Advance) is used to fix the probe near the stimulation site and record the results.
The finger plethysmogram and the local skin blood flow are measured for 10 minutes before stimulation, 2 minutes during stimulation, and 15 minutes after stimulation, for a total of 27 minutes.
Assessment of the type of pain: The presence or absence of "pain" or "de qi" during the stimulation will be assessed after the end of the experiment.
Evaluation of the degree of pain: The intensity of the "pain" or "de qi" is assessed using a visual analogue scale (VAS) of 10 cm in width, respectively, with 100 points as the most intense pain on a scale of every 1 mm, and 0 as the scale indicating no pain.
Base
Study type
Interventional
Study design
Basic design
Cross-over
Randomization
Randomized
Randomization unit
Individual
Blinding
Open -no one is blinded
Control
No treatment
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
3
Purpose of intervention
Treatment
Type of intervention
| Maneuver |
Interventions/Control_1
The acupuncture stimulation group: The experiment will begin after 20 minutes of rest, with 10 minutes of rest before stimulation, 2 minutes during stimulation, and 15 minutes of rest after stimulation, for a total of 27 minutes. The acupuncture stimulation is applied by the sparrow pecking method; that is, the acupuncture needle is inserted and move vertically at the frequency of 1 Hz at a depth of 15-20 mm for 2 minutes. The site of acupuncture stimulation is the LI10 point on the right forearm (between the extensor carpi radialis longus and the extensor carpi radialis brevis on the radial side). Disposable stainless steel needles (40 mm,0.20 mm) are used.
Interventions/Control_2
The thermal stimulation group: The experiment will begin after 20 minutes of rest, with 10 minutes of rest before stimulation, 2 minutes during stimulation, and 15 minutes of rest after stimulation, for a total of 27 minutes. The thermal stimulation is performed using a Pain thermometer (UDH-105, UNIQUE MEDICAL) by applying the attached probe to the stimulation site. The site of thermal stimulation is the LI10 point on the right forearm (between the extensor carpi radialis longus and the extensor carpi radialis brevis on the radial side).
Interventions/Control_3
The control group: The experiment will begin after 20 minutes of rest, with 10 minutes of rest before stimulation, 2 minutes during stimulation, and 15 minutes of rest after stimulation, for a total of 27 minutes.
Nothing is done during stimulation.
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| 30 | years-old | > |
Gender
Male
Key inclusion criteria
1) Healthy person aged 18 and under 30
2) Those who can attend the study site within the study period
3) Persons who can get written consent for participation in this study
Key exclusion criteria
1) Persons who go to the hospital or take medication for basic diseases (chronic respiratory diseases, heart diseases, kidney diseases, liver diseases, diabetes, blood diseases (hyponatremia, difficult-to-treat high blood pressure, etc.), immune function Decreasing illnesses (including malignant tumors), neurological disorders, neuromuscular disorders and severe mental illnesses)
2) Persons who complain of poor physical condition due to sleep disorders
3) Persons who have a habit of excessive smoking * 1 and excessive alcohol intake * 2, and those who have an extremely irregular diet * 3
4) Those who donated 400 ml of blood within 12 weeks, 200 ml of blood within 4 weeks, and component blood within 2 weeks before the start of the experiment
5) Persons participating in other clinical trials
<Notes>
* 1 Excessive smoking generally means smoking 21 or more cigarettes a day.
* 2 Excessive alcohol intake is roughly equivalent to 2 cups of sake per day (500 ml of beer bottle x 2 bottles, whiskey double 60 ml x 2 cups, 1 go of shochu 180 ml, 1 cup of red wine glass 60 ml x 7 cups) or more. Refers to drinking.
* 3 Refers to a state in which one or more meals a day are one or more meals, and the meal time is constantly irregular.
Target sample size
18
Research contact person
Name of lead principal investigator
| 1st name | Kenji |
| Middle name | |
| Last name | Imai |
Organization
Teikyo Heisei University
Division name
Graduate School of Health Sciences
Zip code
170-8445
Address
2-51-4 Higashi-ikebukuro, Toshimaku, Tokyo
TEL
080-1527-1617
k.imai@thu.ac.jp
Public contact
Name of contact person
| 1st name | Namiki |
| Middle name | |
| Last name | Shinozaki |
Organization
Teikyo Heisei University
Division name
Department of Acupuncture and Moxibustion, Graduate School of Health Sciences
Zip code
170-8445
Address
2-51-4 Higashi-ikebukuro, Toshimaku, Tokyo
TEL
080-7698-1412
Homepage URL
n.shinozaki1@gmail.com
Sponsor or person
Institute
Teikyo Heisei University
Institute
Department
Personal name
Funding Source
Organization
Teikyo Heisei University
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
ethical commitie, Teikyo Heisei University
Address
2-51-4 Higashi-ikebukuro, Toshimaku, Tokyo
Tel
03-5843-3111
rec@thu.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2022 | Year | 09 | Month | 15 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2022 | Year | 04 | Month | 20 | Day |
Date of IRB
| 2022 | Year | 09 | Month | 05 | Day |
Anticipated trial start date
| 2022 | Year | 09 | Month | 16 | Day |
Last follow-up date
| 2023 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2022 | Year | 09 | Month | 13 | Day |
Last modified on
| 2022 | Year | 09 | Month | 13 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055743
| Research Plan | |
|---|---|
| Registered date | File name |
| Research case data specifications | |
|---|---|
| Registered date | File name |
| Research case data | |
|---|---|
| Registered date | File name |
